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Background. This article presents evidence-based clinical recommendations for the
use of pit-and-fissure sealants on the occlusal surfaces of primary and permanent molars
in children and adolescents. A guideline panel convened by the American Dental As-
sociation (ADA) Council on Scientific Affairs and the American Academy of Pediatric
Dentistry conducted a systematic review and formulated recommendations to address
clinical questions in relation to the efficacy, retention, and potential side effects of
sealants to prevent dental caries; their efficacy compared with fluoride varnishes; and a
head-to-head comparison of the different types of sealant material used to prevent caries
on pits and fissures of occlusal surfaces.
Types of Studies Reviewed. This is an update of the ADA 2008 recommendations
on the use of pit-and-fissure sealants on the occlusal surfaces of primary and permanent
molars. The authors conducted a systematic search in MEDLINE, Embase, Cochrane
Central Register of Controlled Trials, and other sources to identify randomizedJohn T. Wright, DDS, MS; James J.
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Carrasco-Labra, DDS,MSc, PhD(c)controlled trials reporting on the effect of sealants (available on the US market) when
applied to the occlusal surfaces of primary and permanent molars. The authors used the
Grading of Recommendations Assessment, Development, and Evaluation approach to
assess the quality of the evidence and to move from the evidence to the decisions.
Results. The guideline panel formulated 3 main recommendations. They concluded
that sealants are effective in preventing and arresting pit-and-fissure occlusal carious
lesions of primary and permanentmolars in children and adolescents compared with the
nonuse of sealants or use of fluoride varnishes. They also concluded that sealants could
minimize the progression of noncavitated occlusal carious lesions (also referred to as
initial lesions) that receive a sealant. Finally, based on the available limited evidence, theP it-and-fissure sealantshave been used fornearly 5 decades toprevent and control
carious lesions on primary and
permanent teeth. Sealants are
still underused despite their
documented efficacy and the
availability of clinical practicepanel was unable to provide specific recommendations on the relative merits of 1 type of
sealant material over the others.
Conclusions and Practical Implications. These recommendations are designed
to inform practitioners during the clinical decision-making process in relation to the
prevention of occlusal carious lesions in children and adolescents. Clinicians are
encouraged to discuss the information in this guideline with patients or the parents ofguidelines.1,2 New sealant ma-
terials and techniques continueCopyright ª 2016 American Academy
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patients. The authors recommend that clinicians reorient their efforts toward increasing
the use of sealants on the occlusal surfaces of primary and permanent molars in children
and adolescents.
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PRACTICE GUIDELINESto emerge for managing pit-and-fissure caries, further
complicating the clinician’s decision making. Accord-
ingly, continuous critical review of the available evidence
is necessary to update evidence-based recommenda-
tions and assist health care providers in clinical decision
making.1-7
The American Dental Association (ADA) Council on
Scientific Affairs convened an expert panel to develop
the previous evidence-based clinical recommendations
for the use of sealants, published in 2008.3 In an effort
to update the 2008 recommendations, the ADA Council
on Scientific Affairs and the ADA Center for Evidence-
Based Dentistry, in collaboration with the American
Academy of Pediatric Dentistry (AAPD), convened a
new working group including clinical experts, stake-
holders, and methodologists to develop a systematic
review8 and accompanying evidence-based clinical
practice recommendations for publication in 2016.
Our goal for this 2016 clinical practice guideline was to
provide clinicians with updated evidence-based recom-
mendations regarding when and how the placement of
pit-and-fissure sealants is most likely to be effective
in preventing carious lesions on the occlusal surfaces
of primary and permanent teeth in children and adoles-
cents. The target audience for this guideline includes
general and pediatric dental practitioners and their sup-
port teams, public health dentists, dental hygienists,
pediatricians, primary-care physicians, and community
dental health coordinators; policy makers may also benefit
from this guideline to inform clinical decision making,
programmatic decisions, and public health policy.
DEFINITION OF DENTAL CARIES
Dental caries is a disease caused by an ecological shift in the
composition and activity of the bacterial biofilm when
exposed over time to fermentable carbohydrates, leading
to a break in the balance between demineralization and
remineralization.4 Carious lesions are preventable by
averting onset, and manageable by implementing in-
terventions, whichmay halt progression from early stage of
the disease to cavitation, characterized by enamel demin-
eralization, to frank cavitation.3 In 2015, the ADA pub-
lished the Caries Classification System, which defines a
noncavitated or initial lesion as “initial caries lesion
development, before cavitation occurs. Noncavitated le-
sions are characterized by a change in color, glossiness or
surface structure as a result of demineralization before
there is macroscopic breakdown in surface tooth
structure.”4
EPIDEMIOLOGY
National Health and Nutrition Examination Survey
(NHANES) 2011-20125 data show that 21%of children aged
6 to 11 years and 58% of adolescents aged 12 to 19 years had
experienced carious lesions (untreated and treated
[restored]) in their permanent teeth.The NHANES report also found the prevalence of
carious lesions in permanent teeth increased with age
and differed among sociodemographic groups. Children
in the 9- to 11-year range had higher carious lesion
prevalence (29%) compared with children in the 6- to 8-
year range (14%). Similarly, children in the 16- to 19-year
age range had higher carious lesion prevalence (67%)
compared with children in the 12- to 15-year range (50%).
In addition, dental caries incidence for both 6- to 11-year
and 12- to 19-year age groups was highest among His-
panic children compared with non-Hispanic black chil-
dren, non-Hispanic white children, and Asian children.
The surgeon general’s report on oral health similarly
indicated that Hispanic and non-Hispanic black children
are at the highest risk of developing dental caries.6
Overall, NHANES 2011-2012 indicates a higher preva-
lence of untreated carious lesions in the 12- to 19-year age
group (15%) compared with the 6- to 11-year age group
(6%).5
Although there has been a decline in prevalence of
caries in adolescents and children in particular, the
decrease in occlusal surface caries has not kept pace
with the decrease in the smooth surface caries.7 Although
this overall decline has been attributed to preventive
interventions such as water fluoridation, fluoride tooth-
paste, fluoride varnishes, and sealants, topical fluoride
applications—such as fluoride varnishes—may have a
greater effect reducing carious lesions on smooth sur-
faces compared with caries in pits and fissures.1-7,9,10
NHANES 2011-2012 data show that 41% of children
aged 9 to 11 years and 43% of adolescents aged 12 to
19 years had at least 1 dental sealant. Non-Hispanic
black children had the lowest dental sealant prevalence
in both age groups compared with Hispanic, non-
Hispanic white, and Asian children.5 Therefore, under-
utilization of sealants is of key concern.
POTENTIAL ROLE OF PIT-AND-FISSURE SEALANTS
IN PRIMARY AND SECONDARY PREVENTION
From a primary prevention perspective, anatomic grooves
or pits and fissures on occlusal surfaces of permanent
molars trap food debris and promote the presence of
bacterial biofilm, thereby increasing the risk of developing
carious lesions. Effectively penetrating and sealing these
surfaces with a dental material—for example, pit-and-
fissure sealants—can prevent lesions and is part of a
comprehensive caries management approach.11
From a secondary prevention perspective, there is
evidence that sealants also can inhibit the progressionJADA 147(8) http://jada.ada.org August 2016 673
PRACTICE GUIDELINESof noncavitated carious lesions.9 The use of sealants to
arrest or inhibit the progression of carious lesions is
important to the clinician when determining the appro-
priate intervention for noncavitated carious lesions.
SEALANT MATERIALS AND PLACEMENT TECHNIQUES
For the purposes of this report, there are 4 sealant ma-
terials under a classification proposed by Anusavice
and colleagues11: resin-based sealants, glass ionomer (GI)
cements, GI sealants, polyacid-modified resin sealants,
and resin-modified GI sealants. They defined the mate-
rials as follows.11
-Resin-based sealants are urethane dimethacrylate,
“UDMA,” or bisphenol A-glycidyl methacrylate (also
known as “bis-GMA”) monomers polymerized by either
a chemical activator and initiator or light of a specific
wavelength and intensity. Resin-based sealants come as
unfilled, colorless, or tinted transparent materials or as
filled, opaque, tooth-colored, or white materials.
-GI sealants are cements thatwere developed and are used
for their fluoride-release properties, stemming from the
acid-base reaction between a fluoroaluminosilicate glass
powder and an aqueous-based polyacrylic acid solution.
-Polyacid-modified resin sealants, also referred to as
compomers, combine resin-based material found in
traditional resin-based sealants with the fluoride-
releasing and adhesive properties of GI sealants.
-Resin-modified GI sealants are essentially GI sealants
with resin components. This type of sealant has similar
fluoride-release properties as GI, but it has a longer
working time and less water sensitivity than do tradi-
tional GI sealants.
Placement techniques for pit-and-fissure sealants vary
based on sealant type and the manufacturer or brand.3
Manufacturers’ instructions usually detail cleaning and
isolation of the occlusal surface and encourage a dry
environment during sealant placement and curing.
Acid etching of occlusal surfaces is required before resin-
based sealant placement. Other techniques mentioned
in the studies included in the 2008 report are the use
of bonding agents or adhesives, as well as mechanical
preparations such as air abrasion or enameloplasty.3
CLINICAL QUESTIONS REGARDING PIT-AND-FISSURE
SEALANTS
To assist clinicians in the use of pit-and-fissure sealants
in occlusal surfaces of primary and permanent molars,
the guideline panel developed the following clinical
questions:
- Should dental sealants, when compared with nonuse
of sealants, be used in pits and fissures of occlusal sur-
faces of primary and permanent molars on teeth deemed
to have clinically sound occlusal surfaces or noncavitated
carious lesions?
- Should dental sealants, when compared with fluoride
varnishes, be used in pits and fissures of occlusal surfaces674 JADA 147(8) http://jada.ada.org August 2016of primary and permanent molars on teeth deemed to
have clinically sound occlusal surfaces or noncavitated
carious lesions?
-Which type of sealant material should be used in
pits and fissures of occlusal surfaces of primary and
permanent molars on teeth deemed to have clinically
sound occlusal surfaces or noncavitated carious lesions?
-Are there any adverse events associated with the
use of pit-and-fissure sealants?
METHODS
This clinical practice guideline follows the recommen-
dations of the Appraisal of Guidelines Research &
Evaluation (known as “AGREE”) reporting checklist.10
Guideline panel configuration. The ADA Council
on Scientific Affairs and the AAPD convened a guideline
panel in 2014. The members of this panel were recog-
nized for their level of clinical and research expertise and
represented the different perspectives required for clin-
ical decision making (general dentists, pediatric dentists,
dental hygienists, and health policy makers). Methodol-
ogists from the ADA Center for Evidence-Based
Dentistry oversaw the guideline development process.
Scope and purpose. The purpose of these recom-
mendations is to provide guidance on sealant use for the
prevention of pit-and-fissure occlusal carious lesions in
both primary and permanent molars. The target audi-
ence for this guideline are front-line clinicians in general
practice, pediatric dentists, dental hygienists, dental
therapists, community dental health coordinators, dental
health policy makers and program planners, and other
members of the dental team. Although the evidence
came from various settings, we excluded those sealant
materials not commercially available at the time of this
review.
Retrieving the evidence. Our systematic review
methodology for developing this guideline is presented
elsewhere.8 Briefly, we conducted systematic searches in
MEDLINE, Embase, Cochrane Central Register of
Controlled Trials, and other sources to identify ran-
domized controlled trials reporting on the effect of
sealants (available on the US market) when applied to
the occlusal surfaces of primary and permanent molars.
After pairs of independent reviewers conducted title and
abstract retrieval, full-text screening, and data extraction,
we organized the data retrieved using Grading of Rec-
ommendations Assessment, Development, and Evalua-
tion (GRADE) evidence profiles. In addition, we
requested the guideline panel to rank the relative
importance of outcomes for decision making in 3 cate-
gories (critical, important, and not important) following
guidance from the GRADE working group.12
Assessing the certainty in the evidence. We assessed
the certainty in the evidence (also known as the quality
of the evidence) using the approach described by the
GRADE working group.13 The certainty in the evidence
TABLE 1
Definition of quality of the evidence and strength of recommendations.
EVIDENCE QUALITY AND CERTAINTY DEFINITIONS*
Category Definition
High We are very confident that the true effect lies close to that of the estimate of the effect
Moderate We are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a
possibility that it is substantially different
Low Our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect
Very Low We have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect
DEFINITION OF STRONG AND CONDITIONAL RECOMMENDATIONS AND IMPLICATIONS FOR STAKEHOLDERS†
Implications Strong Recommendations Conditional Recommendations
For Patients Most people in this situation would want the recommended
course of action, and only a small proportion would not; formal
decision aids are not likely to be needed to help people make
decisions consistent with their values and preferences
Most people in this situation would want the suggested course of
action, but many would not
For Clinicians Most people should receive the intervention; adherence to this
recommendation according to the guideline could be used as a
quality criterion or performance indicator
Recognize that different choices will be appropriate for individual
patients and that you must help each patient arrive at a
management decision consistent with his or her values and
preferences; decision aids may be useful in helping people to
make decisions consistent with their values and preferences
For Policy
Makers
The recommendation can be adapted as policy in most
situations
Policy making will require substantial debate and involvement of
various stakeholders
* Reproduced with permission of the publisher from Balshem and colleagues.13
† Sources: Andrews and colleagues.14,15
PRACTICE GUIDELINESin the context of clinical practice guidelines reflects the
extent to which the guideline panel felt confident about
the estimates of effect used for the decision-making
process. The GRADE approach classifies the certainty
in the evidence as high, moderate, low, or very low
(Table 113-15), depending on whether the body of evidence
at an outcome level includes serious or very serious
issues as follows:
-Risk of bias: When the studies that are part of the
body of evidence are affected by serious or very serious
limitations in study design, the confidence in the esti-
mates of effect is reduced owing to the increased risk of
bias.16
- Imprecision: When the confidence intervals (CIs) of
the data used for the treatment effects are too wide to
make decisions, the confidence in the estimates of effect
is reduced owing to issues of imprecision. Typically,
imprecision occurs when the CIs suggest both a large
benefit on one side and a large harm on the other side.17
- Inconsistency: When the studies comprising the
body of evidence provide inconsistent results, the
confidence in the estimates of effect is reduced owing
to the unexplained heterogeneity among them.18
- Indirectness: When the population, interventions,
comparator, or outcomes reported in the studies
comprising the body of evidence do not directly match
the ones the panel requires to make an informed deci-
sion, the confidence in the estimates of effect is reduced
owing to this mismatching issue.19
-Publication bias: When there is suspicion that not
all studies conducted to inform a particular treatment
effect are available or they were selectively publishedor unpublished, the confidence in the estimates of effect
is reduced owing to the suspicion of reporting bias.20
Moving from the evidence to the decisions. To assist
the guideline panel with formulating recommendations
and grading the strength of the recommendations, we
used the evidence-to-decision framework, including the
following domains: balance between the desirable and
undesirable consequences (net effect), certainty in the
evidence (also called quality of the evidence), patients’
values and preferences, and resource use.14,15 According
to the GRADE approach, the strength of a recommen-
dation is either strong or conditional, in which each
grade of the strength has different implications for
patients, clinicians, and policy makers (Table 1).
The guideline recommendations in this article were
formulated collectively via 3 videoconferences with
members of the guideline panel and methodologists from
the ADA Center for Evidence-Based Dentistry and the
AAPD held in January 2016. Deliberation and consensus
were the main methods to develop these recommenda-
tions using the “evidence-to-decision” framework.14,15
When consensus was elusive, the panel was presented
with the positions under assessment, and it voted
accordingly.21 We identified potential conflicts of interest
and managed them according to the recommendations
from the World Health Organization and other guideline
development agencies.22
Guideline updating process. The ADA Center for
Evidence-Based Dentistry and the AAPD monitor the
literature to identify new studies that may be included in
the recommendations. These recommendations will be
updated 5 years from the date of submission forJADA 147(8) http://jada.ada.org August 2016 675
TABLE 2
Summary of clinical recommendations on the use of pit-and-fissure sealants
in the occlusal surfaces of primary and permanent molars in children and
adolescents.
QUESTION RECOMMENDATION QUALITY OF THE
EVIDENCE
STRENGTH OF
RECOMMENDATION
Should dental sealants, when compared with
nonuse of sealants, be used in pits and
fissures of occlusal surfaces of primary and
permanent molars on teeth deemed to have
clinically sound occlusal surfaces or
noncavitated carious lesions?
The sealant guideline panel recommends the
use of sealants compared with nonuse in
permanent molars with both sound occlusal
surfaces and noncavitated occlusal carious
lesions in children and adolescents*
Moderate Strong
Should dental sealants, when compared with
fluoride varnishes, be used in pits and
fissures of occlusal surfaces of primary and
permanent molars on teeth deemed to have
clinically sound occlusal surfaces or
noncavitated carious lesions?
The sealant guideline panel suggests the use of
sealants compared with fluoride varnishes in
permanent molars with both sound occlusal
surfaces and noncavitated occlusal carious
lesions in children and adolescents*
Low Conditional
Which type of sealant material should be
used in pits and fissures of occlusal surfaces
of primary and permanent molars on teeth
deemed to have clinically sound occlusal
surfaces or noncavitated carious lesions?
The panel was unable to determine superiority of
1 type of sealant over another owing to the very
low quality of evidence for comparative studies;
the panel recommends that any of the materials
evaluated (for example, resin-based sealants,
resin-modified glass ionomer sealants, glass
ionomer cements, and polyacid-modified resin
sealants, in no particular order) can be used for
application in permanent molars with both
sound occlusal surfaces and noncavitated
occlusal carious lesions in children and
adolescents (conditional recommendation, very
low–quality evidence)*,†
Very low Conditional
* These recommendations are applicable to both sound surfaces and noncavitated carious lesions: “Noncavitated lesions are characterized by a change
in color, glossiness, or surface structure as a result of demineralization before there is macroscopic breakdown in surface tooth structure. These
lesions represent areas with net mineral loss due to an imbalance between demineralization and remineralization. Reestablishing a balance
between demineralization and remineralization may stop the caries disease process while leaving a visible clinical sign of past disease.”4
† The guideline panel suggests that clinicians should take into account the likelihood of experiencing lack of retention when choosing the type of
sealant material most appropriate for a specific patient and clinical scenario. For example, in situations in which dry isolation is difficult, such as a
tooth that is not fully erupted and has soft tissue impinging on the area to be sealed, then a material that is more hydrophilic (for example, glass
ionomer) would be preferable to a hydrophobic resin-based sealant. On the other hand, if the tooth can be isolated to ensure a dry site and long-
term retention is desired, then a resin-based sealant may be preferable.
PRACTICE GUIDELINESpublication or when new evidence dictates that the panel
change the course of action suggested in this guideline.
RECOMMENDATIONS
How to use these recommendations. The recommen-
dations in this clinical practice guideline aim to assist
patients, clinicians, and other stakeholders when making
health care decisions. Although this clinical practice
guideline covers the typical patient that the target audi-
ence treats on a daily basis, there may be specific situa-
tions in which clinicians may want to deviate from the
recommendations listed below. Clinical expertise plays a
key role in determining which patients fit into the scope
of this guideline and how these recommendations align
with the values, preferences, and the context of
an individual patient.23
When the panel grades a recommendation as strong,
this means that in most situations clinicians may want
to follow the course of action suggested by the panel
and only in a selected few circumstances may they
need to deviate from it. Strong recommendations are676 JADA 147(8) http://jada.ada.org August 2016usually associated with benefits or harms clearly out-
weighing one over the other, based on high- to
moderate-quality evidence (certainty in the evidence),
overall homogeneous values and preferences among
patients, and inexpensive or easy-to-implement in-
terventions.14,15 Conditional recommendations, on the
other hand, indicate that clinicians may want to follow
the course of action suggested by the panel; however, the
panel also recognizes that different choices would be
appropriate for individual patients. This type of recom-
mendation is usually associated with a close balance
between benefits and harms, low- to very low–quality
evidence, important variability in patients’ values and
preferences, and substantial costs or challenges when
trying to implement the intervention (Table 1).4,14,15
When facing a conditional recommendation, clinicians
should pay special attention to the reasons that justify
such judgment from the guideline panel. This informa-
tion can be found in the remarks section presented with
each recommendation. Table 2 shows a summary of
the key recommendations included in this guideline.
PRACTICE GUIDELINESQuestion 1. Should dental sealants, when compared
with nonuse of sealants, be used in pits and fissures
of occlusal surfaces of primary and permanent molars
on teeth deemed to have clinically sound occlusal
surfaces or noncavitated carious lesions?
Summary of findings. Data from 9 randomized
controlled trials9,24-31 showed that in children and
adolescents with sound occlusal surfaces, the use of pit-
and-fissure sealants compared with nonuse of sealants,
reduces the incidence of occlusal carious lesions in per-
manent molars by 76% after 2 to 3 years of follow-up
(odds ratio [OR], 0.24; 95% CI, 0.19-0.30) (eTable 1,
available online at the end of this article). In absolute
terms, for a population with a caries baseline risk
(prevalence) of 30%, 207 carious lesions would be pre-
vented out of 1,000 sealant applications (95% CI, 186-225
fewer lesions) after 2 to 3 years of follow-up. Available
data assessing the effect of sealants compared with a
control without sealants in a mixed population of pa-
tients with sound occlusal surfaces and noncavitated
occlusal carious lesions showed that sealants reduced the
incidence of carious lesions in this population by 75%
(OR, 0.25; 95% CI, 0.19-0.34) after 2 to 3 years of follow-
up. The guideline panel determined the overall quality of
the evidence for this comparison as moderate owing to
serious issues of risk of bias (unclear method for
randomization and allocation concealment) in the
included studies. No data on the effect of sealants in
adult patients were identified.
Recommendation. The sealant guideline panel rec-
ommends the use of sealants compared with nonuse in
primary and permanent molars with both sound occlusal
surfaces and noncavitated occlusal carious lesions in
children and adolescents. (Strong recommendation,
moderate-quality evidence.)
Remarks.
-No studies were identified regarding the effect of
sealants on preventing and arresting occlusal carious
lesions in adult patients. For clinicians and patients
attempting to extend this recommendation to adults,
the guideline panel suggests that similar treatment ef-
fects may be expected for other age groups, particularly
in adults with a recent history of dental caries. The
lack of direct evidence informing this recommendation
restrained the guideline panel from formulating a more
definitive recommendation in this regard.
-This recommendation is intended to inform clini-
cians about the benefit of sealing a tooth compared
with not sealing it, irrespective of the type of sealant
material applied.
-The panel highlighted that a number of studies have
shown that sealing children’s and adolescents’ perma-
nent molars reduces costs to the health system by de-
laying and preventing the need for invasive restorative
treatment, particularly when these patients are classified
as having an “elevated caries risk” (that is, previous cariesexperience).32 Under these conditions, dental sealants
seem to be a cost-effective intervention.33-36
- In addition to the evidence collected by the panel
from randomized controlled trials suggesting a benefi-
cial effect of sealants in noncavitated occlusal carious
lesions, the body of evidence from observational studies
shows similar results.37,38
Research priorities.
-Although the analysis was stratified using 2 caries
baseline risks (30% caries prevalence in the article
and 70% caries prevalence in the tables), the guideline
panel acknowledged that clinicians lack a valid and
reliable tool to conduct a chairside caries risk assessment,
especially when it comes to assessing a specific tooth
surface or site. There is a need for such a tool to enable
clinicians to perform a more accurate assessment of the
patient’s caries risk and to enable the panel to provide
more specific recommendations using an accurate pa-
tient caries risk estimation.
-The panel highlighted the need for additional studies
assessing the effect of sealants in the primary dentition.
Question 2. Should dental sealants, when compared
with fluoride varnishes, be used in pits and fissures
of occlusal surfaces of primary and permanent molars
on teeth deemed to have clinically sound occlusal
surfaces or noncavitated carious lesions?
Summary of findings. Data from 3 randomized
controlled trials25,27,39 suggest that in children and
adolescents with sound occlusal surfaces, the use of pit-
and-fissure sealants compared with fluoride varnishes
may reduce the incidence of occlusal carious lesions
in permanent molars by 73% after 2 to 3 years of follow-
up (OR, 0.27; 95% CI, 0.11-0.69) (eTable 2, available
online at the end of this article). In absolute terms, for
a population with a caries baseline risk (prevalence) of
30%, 196 carious lesions would be prevented out of 1,000
sealant applications (95% CI, 72-255 fewer lesions) when
using sealants compared with using fluoride varnish
after 2 to 3 years of follow-up. When assessing the effect
of sealants compared with fluoride varnishes in a mixed
population of patients with sound occlusal surfaces and
noncavitated occlusal carious lesions, sealants may
reduce the incidence of caries by 34%; however, this
difference was not statistically significant (OR, 0.66; P ¼
.30; 95% CI, 0.30-1.44). The guideline panel determined
the overall quality of the evidence for this comparison as
low owing to serious issues of risk of bias (unclear
method for randomization and allocation concealment)
and inconsistency. No data on the effect of sealants
versus fluoride varnish in adult patients were identified.
Recommendation. The sealant guideline panel
suggests the use of sealants compared with fluoride
varnishes in primary and permanent molars, with
both sound occlusal surfaces and noncavitated oc-
clusal carious lesions, in children and adolescents.JADA 147(8) http://jada.ada.org August 2016 677
PRACTICE GUIDELINES(Conditional recommendation, low-quality
evidence.)
Research priorities.
-Although the analysis was stratified using 2 caries
baseline risks (30% caries prevalence in the article and
70% caries prevalence in the tables), the guideline panel
acknowledged that clinicians lack a valid and reliable tool
to conduct a chairside caries risk assessment. There is a
need for such a tool to enable clinicians to understand the
evidence in the context of different caries risk estimations.
-The guideline panel suggests that more research
should be conducted on other noninvasive approaches
for caries arrest in occlusal surfaces of primary and
permanent molars (for example, silver diamine fluoride).
Question 3. Which type of sealant material should
be used in pits and fissures of occlusal surfaces of
primary and permanent molars on teeth deemed to
have clinically sound occlusal surfaces or noncavitated
carious lesions in children and adolescents?
Comparison 3.1. GI sealants compared with resin-
based sealants.
Summary of findings. Data from 10 randomized
controlled trials40-49 included in the meta-analysis suggest
that in children and adolescents with sound occlusal sur-
faces, the use of GI sealants compared with resin-based
sealants may reduce the incidence of occlusal carious le-
sions in permanent molars by 37% after 2 to 3 years of
follow-up (OR, 0.71; 95% CI, 0.32-1.57); however, this dif-
ference was not statistically significant (P¼ .39) (eTable 3,
available online at the end of this article). In absolute
terms, for a population with a caries baseline risk (preva-
lence) of 30%, this means that use of a GI sealant would
prevent 67 carious lesions out of 1,000 sealant applications
(95% CI, 102more-179 fewer lesions) compared with using
a resin-based sealant after 2 to 3 years of follow-up; how-
ever, this difference was not statistically significant. One
additional study with 200 participants that we were unable
to include in the meta-analysis owing to the data presen-
tation failed to show a clinically or statistically significant
difference in caries incidence when GI sealants and
resin-based sealants were placed on the occlusal surfaces of
primary and permanent molars.50 When looking at
available data assessing the effect of GI sealants compared
with resin-based sealants in a population of patients with
noncavitated occlusal carious lesions, the data suggest that
GI sealants may increase the incidence of carious lesions
by 53% (OR, 1.53; 95% CI, 0.58-4.07); however, this differ-
ence was not statistically significant (P ¼ .39). When
assessing retention, glass ionomer sealants may have 5
times greater risk of experiencing loss of retention from
the tooth compared with resin-based sealants after 2 to 3
years of follow-up (OR, 5.06; 95% CI, 1.81-14.13). The
guideline panel determined the overall quality of the evi-
dence for this comparison as very low owing to serious
issues of risk of bias (unclear method for randomization
and allocation concealment), inconsistency, and678 JADA 147(8) http://jada.ada.org August 2016imprecision. No data on the effect of GI versus resin-based
sealants in adult patients were identified.
Comparison 3.2. Glass ionomer sealants compared
with resin-modified GI sealants
Summary of findings. Data from 1 randomized
controlled trial29 suggest that in children and adolescents
with sound occlusal surfaces the use of GI sealants
compared with resin-modified GI sealants may increase
the incidence of occlusal carious lesions in permanent
molars by 41% after 2 to 3 years of follow-up (OR, 1.41;
95% CI, 0.65-3.07); however, this difference was not sta-
tistically significant (P ¼ .38) (eTable 4, available online
at the end of this article). In absolute terms, for a pop-
ulation with a caries baseline risk (prevalence) of 30%,
we are expecting to have 77 more carious lesions over
1,000 sealant applications (95% CI, 82 fewer-268 more
lesions) when using GI sealants compared with using a
resin-modified glass ionomer sealant after 2 to 3 years of
follow-up; however, this difference was not statistically
significant. When assessing retention, GI sealants would
have 3 times greater risk of experiencing retention loss
from the tooth compared with resin-modified glass
ionomer sealants after 2 to 3 years of follow-up (OR, 3.21;
95% CI, 1.87-5.51). The guideline panel determined the
overall quality of the evidence for this comparison as
very low owing to serious issues of risk of bias (unclear
method for randomization and allocation concealment),
and very serious issues of imprecision. No data on the
effect of GI versus resin-modified GI sealants in adult
patients were identified.
Comparison 3.3. Resin-modified glass ionomer
sealants compared with polyacid-modified resin
sealants.
Summary of findings. Data from 1 randomized
controlled trial48 suggest that in children and adolescents
with sound occlusal surfaces, the use of resin-modified
GI sealants compared with polyacid-modified GI sealants
may reduce the incidence of occlusal carious lesions in
permanent molars by 56% after 2 to 3 years of follow-up
(OR, 0.44; 95% CI, 0.11-1.82); however, this difference was
not statistically significant (P ¼ .26) (eTable 5, available
online at the end of this article). In absolute terms, for a
population with a caries baseline risk (prevalence) of 30%
this means that use of resin-modified GI sealants would
prevent 141 carious lesions out of 1,000 sealant applica-
tions (95% CI, 138 more-255 fewer lesions) compared
with the use of polyacid-modified resin sealants after 2 to
3 years of follow-up; but this difference was not statis-
tically significant. When assessing retention, resin-
modified GI sealants may increase the risk of loss of
retention by 17% compared with polyacid-modified resin
sealants after 2 to 3 years of follow-up (OR, 1.17; 95% CI,
0.52-2.66); however, this difference was not statistically
significant (P ¼ .70). The guideline panel determined the
overall quality of the evidence for this comparison as
very low owing to serious issues of risk of bias (unclear
PRACTICE GUIDELINESmethod for randomization and allocation concealment)
and very serious issues of imprecision. No data on the
effect of resin-modified versus polyacid-modified resin
sealants in adult patients were identified.
Comparison 3.4. Polyacid-modified resin sealants
compared with resin-based sealants.
Summary of findings. Data from 2 randomized
controlled trials48,51 suggest that in children and ado-
lescents with sound occlusal surfaces, the use of
polyacid-modified resin sealants compared with resin-
based sealants may increase the incidence of occlusal
carious lesions in permanent molars by 1% after 2 to 3
years of follow-up (OR, 1.01; 95% CI, 0.48-2.14); how-
ever, this difference was not statistically significant (P ¼
.97) (eTable 6, available online at the end of this article).
In absolute terms, for a population with a caries baseline
risk (prevalence) of 30%, the use of polyacid-modified
resin sealant would increase carious lesions by 2 out of
1,000 sealant applications (95% CI, 129 fewer-178 more
lesions) compared with using a resin-based sealant after
2 to 3 years of follow-up; however, this difference was
not statistically significant. When assessing the outcome
retention, polyacid-modified resin sealants seem to
reduce the risk of loss of retention by 13% compared
with resin-based sealants after 2 to 3 years of follow-up
(OR, 0.87; 95% CI, 0.12-6.21); however, this difference
was not statistically significant (P ¼ .89). The guideline
panel determined the overall quality of the evidence for
this comparison as very low owing to serious issues of
risk of bias (unclear method for randomization and
allocation concealment) and very serious issues of
imprecision. No data on the effect of polyacid-modified
resin versus resin-based sealants in adult patients were
identified.
Recommendation. The panel was unable to deter-
mine superiority of 1 type of sealant over another owing
to the very low quality of evidence for comparative
studies. The panel recommends that any of the materials
evaluated (for example, resin-based sealants, resin-
modified GI sealants, GI cements, and polyacid-modified
resin sealants in no particular order) can be used for
application in permanent molars with both sound
occlusal surfaces and noncavitated occlusal carious le-
sions in children and adolescents. (Conditional recom-
mendation, very low–quality evidence.)
Remarks.
-The head-to-head analyses of all comparisons did not
allow the guideline panel to provide specific recom-
mendations using a hierarchy of effectiveness for the
sealant materials. In addition, the quality of the evidence
across head-to-head comparisons was assessed to be low
to very low at best. The guideline panel suggests that
clinicians take into account the likelihood of experi-
encing lack of retention when choosing the type of
sealant material most appropriate for a specific patient
and clinical scenario. For example, in situations in whichdry isolation is difficult, such as a tooth that is not fully
erupted and has soft tissue impinging on the area to be
sealed, then a material that is more hydrophilic (for
example, GI) would be preferable to a hydrophobic
resin-based sealant. On the other hand, if the tooth can
be isolated to ensure a dry site and long-term retention is
desired, then a resin-based sealant may be preferable.
-The lack of reporting in relation to resealing did not
allow the panel to include this as 1 more element for
decision making. However, it can be inferred from the
data on retention loss that clinicians may need to
monitor sealants showing a higher risk of experiencing
retention loss more often.
-To obtain optimal levels of retention, the guideline
panel suggests clinicians carefully follow the manufac-
turers’ instructions for each type of sealant material.
Research priorities.
-The panel urges the research community to conduct
high-quality randomized controlled trials to understand
further the relative merits of the different types of sealant
materials. Such studies should meet the optimal infor-
mation size17 to reduce the very serious issues of
imprecision affecting this body of evidence.
-New trials should improve reporting quality to
allow the panel to conduct a more accurate assessment
of the risk of bias.
- Further research is needed to understand the role of
different types of sealant materials in the primary
dentition and adult population.
-Although the analysis conducted was stratified
using 2 caries baseline risks (30% caries prevalence in
the article and 70% caries prevalence in the tables), the
guideline panel acknowledged that clinicians lack a
reliable and valid chairside tool to conduct a caries risk
assessment. There is a need for such a tool to enable
clinicians to extrapolate the results from this analysis
to their patients in a more accurate manner.
-The poor quality or complete lack of reporting in
relation to resealing prevented the panel from using
this information during the decision-making process.
The panel highlighted the need for improving the report
of reapplication of sealants as 1 more relevant outcome
in primary studies assessing the effect of this
intervention.
Question 4. Are there any adverse events when
using pit-and-fissure sealants?
Summary of findings. There has been concern that
dental sealants might exhibit adverse effects. This is
primarily associated with bisphenol A (BPA). It has been
suggested that the BPA present in some sealants may
have estrogenlike effects52,53; however, the evidence does
not support the transient effect of a small amount of BPA
in placing patients at risk.54 Studies also have evaluated
the correlation of developing carious lesions in teeth
with fully or partially lost sealants and found no greater
risk than in teeth that had never been sealed.55 TwoJADA 147(8) http://jada.ada.org August 2016 679
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of adverse effects associated with sealants found no
events related to this outcome.27,56,57
CONCLUSIONS
The evidence shows that sealants available in the US
market at the time of this systematic review are an
effective intervention for reducing the incidence of
carious lesions in the occlusal surfaces of primary
and permanent molars in children and adolescents
compared with the nonuse of sealants or fluoride var-
nishes. This benefit is inclusive to both sound occlusal
surfaces and noncavitated occlusal carious lesions.
Clinicians should use these recommendations but
consider carefully individual patient factors, especially
where the guideline panel offered conditional recom-
mendations. In addition, sealant use should be increased
along with other preventive interventions to manage the
caries disease process, especially in patients with an
elevated risk of developing caries. Further research is
needed to provide more risk-oriented recommendations,
particularly regarding the development of a valid and
reliable chairside tool for clinicians to assess a patient’s
caries risk. n
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eTABLE 1
Evidence profile: sealants compared with nonuse of sealants in pit-and-fissure
occlusal surfaces in children and adolescents.*
QUALITY ASSESSMENT
No. of Studies Study Design Risk of Bias Inconsistency Indirectness Imprecision Other Considerations
Caries incidence (follow-up: range 2-3 y)‡
9 Randomized trials Serious§ Not serious Not serious Not serious None
Caries incidence (follow-up: range 4-7 y)#
3 Randomized trials Serious§ Serious** Not serious Not serious None
Caries incidence (follow-up: range 7 y or more)#
2 Randomized trials Serious§ Not serious Not serious Not serious None
Lack of retention (follow-up: range 2-3 y)
9 Randomized trials Serious§ Not serious Not serious Not serious None
* Sources: Bravo and colleagues,e1 Liu and colleagues,e2 Mertz-Fairhurst and colleagues,e3 Splieth and colleagues,e4 Bojanini and colleagues,e5
Richardson and colleagues,e6 Erdogan and colleagues,e7 Tagliaferro and colleagues,e8 and Pereira and colleagues.e9
† The percentages (30% and 70%) indicate the control group baseline risk (caries prevalence).
‡ A subgroup analysis conducted to determine whether there was a difference in the caries incidence depending on whether the sealant was placed
in patients with noncavitated carious lesions or deep fissures and pits, no caries in the occlusal surface, and a mix of caries free and noncavitated
carious lesions, showed no statistically significant differences (P ¼ .58). Studies including a mixed population (recruiting both patients with non-
cavitated initial occlusal caries and caries-free occlusal surfaces) showed a 76% reduction in caries incidence after 2- to 3-y follow-up (odds ratio,
0.24; 95% confidence interval, 0.19-0.30).
§ Most studies were classified as unclear for the “allocation concealment” and “masking” domains.
¶ 4 of 9 studies reported being conducted in water-fluoridated communities.
# Studies only reported data for this outcome in patients who were caries-free. Patients with noncavitated carious lesions or deep pits and fissures
were not included in the studies.
** Unexplained heterogeneity (P < .0001, I2 ¼ 77%).
†† 2 of 3 studies reported being conducted in water-fluoridated communities.
‡‡ 2 of 2 studies reported being conducted in water-fluoridated communities.
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eTABLE 1 (CONTINUED)
PATIENTS (N) EFFECT QUALITY IMPORTANCE
Sealants Nonuse of
Sealants†
Relative Odds Ratio
(95% Confidence
Interval)
Absolute (95% Confidence Interval)
194/1,799 (12.0%) 584/1,743 (37.3%)¶ 0.24 (0.19-0.30) 248 fewer per 1,000 (221-271 fewer) Moderate Critical
30.0% 207 fewer per 1,000 (186-225 fewer)
70.0% 341 fewer per 1,000 (288-393 fewer)
74/368 (20.1%) 206/384 (53.6%)†† 0.21 (0.10-0.44) 341 fewer per 1,000 (199-433 fewer) Low Critical
30.0% 217 fewer per 1,000 (141-259 fewer)
70.0% 371 fewer per 1,000 (193-511 fewer)
62/215 (28.8%) 170/231 (73.6%)‡‡ 0.15 (0.08-0.27) 441 fewer per 1,000 (307-554 fewer) Moderate Critical
30.0% 240 fewer per 1,000 (196-267 fewer)
70.0% 441 fewer per 1,000 (313-543 fewer)
Including all sealant material types and tooth preparation techniques, 55.6% of sealants were fully retained at
2 y, and 59.3% were fully or partially retained at 2 y; at 3 y, 56.4% of all sealants were fully retained, and
58.8% were fully or partially retained after 3.6 y
Moderate Important
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eTABLE 2
Evidence profile: sealants compared with fluoride varnishes in pit-and-fissure
occlusal surfaces in children and adolescents.*
QUALITY ASSESSMENT
No. of Studies Study Design Risk of Bias Inconsistency Indirectness Imprecision Other Considerations
Caries incidence (follow-up: range 2-3 y)‡
3 Randomized trials Serious§ Serious¶ Not serious Not serious None
Caries incidence (follow-up: range 4-7 y)**
2 Randomized trials Serious§ Serious†† Not serious Not serious None
Caries incidence (follow-up: range 7 y or more)
1 Randomized trials Very serious§ Not serious Not serious Not serious None
Lack of retention (follow-up: range 2-3 y)
2 Randomized trials Serious§ Not serious Not serious Not serious None
* Sources: Houpt and colleagues,e10 Bravo and colleagues,e1 and Liu and colleagues.e2
† The percentages (30% and 70%) indicate the control group baseline risk (caries prevalence).
‡ A subgroup effect was identified for this outcome (P ¼ .04). Patients who were caries-free (odds ratio, 0.19; 95% confidence interval, 0.07-0.47)
and mixed population (odds ratio, 0.66; 95% confidence interval, 0.30-1.44).
§ Most studies were classified as unclear for the “allocation concealment” and “masking” domains.
¶ Unexplained heterogeneity (P ¼ .0002, I2 ¼ 88%).
# 2 of 3 studies reported being conducted in water-fluoridated communities.
** The studies only reported the outcome in patients who were caries-free.
†† Unexplained heterogeneity (P ¼ .03, I2 ¼ 80%).
‡‡ 2 of 2 studies reported being conducted in water-fluoridated communities.
§§ The study reported being conducted in water-fluoridated communities.
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eTABLE 2 (CONTINUED)
PATIENTS (N) EFFECT QUALITY IMPORTANCE
Sealants Fluoride Varnishes† Relative Odds Ratio
(95% Confidence
Interval)
Absolute (95% Confidence
Interval)
66/855 (7.7%) 364/860 (42.3%)# 0.27 (0.11-0.69) 258 fewer per 1,000 (87-349 fewer) Low Critical
30.0% 196 fewer per 1,000 (72-255 fewer)
70.0% 313 fewer per 1,000 (83-496 fewer)
46/228 (20.2%) 131/244 (53.7%)‡‡ 0.19 (0.07-0.51) 356 fewer per 1,000 (165-462 fewer) Low Critical
30.0% 225 fewer per 1,000 (121-271 fewer)
70.0% 393 fewer per 1,000 (157-560 fewer)
30/113 (26.5%) 72/129 (55.8%)§§ 0.29 (0.17-0.49) 290 fewer per 1,000 (176-381 fewer) Low Critical
30.0% 189 fewer per 1,000 (126-232 fewer)
70.0% 296 fewer per 1,000 (167-416 fewer)
Including all sealant material types and tooth preparation techniques, 55.6% of sealants were fully
retained at 2 y, and 59.3% were fully or partially retained at 2 y; at 3 y, 56.4% of all sealants were fully
retained, and 58.8% were fully or partially retained at 3 y
Moderate Important
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eTABLE 3
Evidence profile: glass ionomer sealants compared with resin-based sealants in
pit-and-fissure occlusal surfaces in children and adolescents.*
QUALITY ASSESSMENT
No. of Studies Study Design Risk of Bias Inconsistency Indirectness Imprecision Other Considerations
Caries incidence (follow-up: range 2-3 y)‡,§
10 Randomized trials Serious¶ Serious# Not serious Serious** None
Caries incidence (follow-up: range 4-7 y)‡‡
2 Randomized trials Serious§§ Not serious Not serious Very serious¶¶ None
Caries incidence (follow-up: range 7 y or more)—not reported
—## — — — — — —
Lack of retention (follow-up: range 2-3 y)
10 Randomized trials Serious¶ Serious*** Not serious Not serious None
Lack of retention (follow-up: range 4-7 y)
2 Randomized trials Serious§§ Not serious Not serious Serious††† None
Lack of retention—not reported
— — — — — — —
* Sources: Chen and colleagues,e11,e12 Chen and Liu,e13 Amin,e14 Antonson and colleagues,e15 Arrow and Riordan,e16 Baseggio and colleagues,e17
Pardi and colleagues,e18 Guler and Yilmaz,e19 Dhar and Chen,e20 and Haznedaroglu and Guner.e21
† The percentages (30% and 70%) indicate the control group baseline risk (caries prevalence).
‡ A subgroup analysis conducted to determine whether there was a difference in the caries incidence depending on whether the sealant was placed
in noncavitated carious lesions or deep fissures and pits, no caries in the occlusal surface, and a mix of caries free and noncavitated carious lesions,
showed no statistically significant differences (odds ratio, 1.53; 95% confidence interval, 0.58-4.07; P ¼ .19).
§ One additional study including 200 participants that was not included in the meta-analysis due to the data presentation failure to show a clinically
or statistically significant difference in caries incidence when glass ionomer sealants and resin-based sealants were placed in the occlusal surfaces
of primary and permanent teeth.
¶ Most studies were classified as unclear for the “allocation concealment” and “masking” domains.
# Unexplained heterogeneity (P < .00001, I2 ¼ 81%).
** 95% confidence interval suggests large benefit and a large harm (95% confidence interval, 68% reduction-57% increase).
†† 1 of 10 studies reported being conducted in water-fluoridated communities.
‡‡ Only 2 studies reported this outcome. No subgroup analysis was conducted.
§§ The “randomization” and “allocation concealment” domains were classified as “unclear” risk of bias for most studies.
¶¶ 95% confidence interval suggests a large benefit and a large harm (95% confidence interval, 96% reduction-0% increase).
## Dashes indicate data not available.
*** Unexplained heterogeneity (P # .00001, I2 ¼ 97%).
††† 95% confidence interval suggests a large benefit and a large harm (95% confidence interval, 85% reduction-2,695% increase).
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eTABLE 3 (CONTINUED)
PATIENTS (N) EFFECT QUALITY IMPORTANCE
Glass Ionomer
Sealants
Resin-Based
Sealants†
Relative Odds Ratio
(95% Confidence
Interval)
Absolute (95% Confidence
Interval)
179/2,727 (6.6%) 141/2,014 (7.0%)†† 0.71 (0.32-1.57) 19 fewer per 1,000 (36 more-46
fewer)
Very low Critical
30.0% 67 fewer per 1,000 (102 more-179
fewer)
70.0% 76 fewer per 1,000 (86 more-273
fewer)
6/61 (9.8%) 19/84 (22.6%) 0.37 (0.14-1.00) 154 fewer per 1,000 (0-228 fewer) Very low Critical
30.0% 163 fewer per 1,000 (0-243 fewer)
70.0% 237 fewer per 1,000 (0-454 fewer)
— — — — — Critical
1875/2,727 (68.8%) 596/2,014 (29.6%) 5.06 (1.81-14.13) 384 more per 1,000 (136-560 more) Low Important
46/61 (75.4%) 50/84 (59.5%) 2.08 (0.15-27.95) 158 more per 1,000 (381 more-415
fewer)
Low Important
— — — — — Important
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eTABLE 4
Evidence profile: glass ionomer sealants compared with resin-modified glass
ionomer sealants in pit-and-fissure occlusal surfaces in children and adolescents.*
QUALITY ASSESSMENT
No. of Studies Study Design Risk of Bias Inconsistency Indirectness Imprecision Other Considerations
Caries incidence (follow-up: range 2-3 y)‡
1 Randomized trials Serious§ Not serious Not serious Very serious¶ None
Caries incidence (follow-up: range 4-7 y)—not reported
—** — — — — — —
Caries incidence (follow-up: range 7 y or more)—not reported
— — — — — — —
Lack of retention (follow-up: range 2-3 y)
1 Randomized trials Serious§ Not serious Not serious Not serious None
Lack of retention (follow-up: range 4-7 y)—not reported
— — — — — — —
Lack of retention (follow-up: range 7 y or more)—not reported
— — — — — — —
* Source: Pereira and colleages.e9
† The percentages (30% and 70%) indicate the control group baseline risk (caries prevalence).
‡ Only 1 study reported this outcome. No subgroup analysis was included.
§ All domains were classified as unclear, including the “allocation concealment” and “masking” domains.
¶ The 95% confidence interval suggests an appreciable benefit and an appreciable harm (95% confidence interval, 45% reduction-207% increase in
caries incidence).
# The study was conducted in water-fluoridated communities.
** Dashes indicate data not available.
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eTABLE 4 (CONTINUED)
PATIENTS (N) EFFECT QUALITY IMPORTANCE
Glass Ionomer
Sealants
Resin-Modified
Glass Ionomer
Sealants†
Relative Odds Ratio
(95% Confidence
Interval)
Absolute (95% Confidence
Interval)
27/172 (15.7%) 20/172 (11.6%)# 1.41 (0.65-3.07) 40 more per 1,000 (37 fewer-171
more)
Very low Critical
30.0% 77 more per 1,000 (82 fewer-268
more)
70.0% 67 more per 1,000 (97 fewer-178
more)
— — — — — Critical
— — — — — Critical
149/172 (86.6%) 115/172 (66.9%) 3.21 (1.87-5.51) 198 more per 1,000 (122-249 more) Moderate Important
— — — — — Important
— — — — — Important
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eTABLE 5
Evidence profile: resin-modified glass ionomer sealants compared with
polyacid-modified resin sealants in pit-and-fissure occlusal surfaces in
children and adolescents.*
QUALITY ASSESSMENT
No. of Studies Study Design Risk of Bias Inconsistency Indirectness Imprecision Other Considerations
Caries incidence (follow-up: range 2-3 y)‡
1 Randomized trials Serious§ Not serious Not serious Very serious¶ None
Caries incidence (follow-up: range 4-7 y)—not reported
—** — — — — — —
Caries incidence (follow-up: range 7 y or more)—not reported
— — — — — — —
Lack of retention (follow-up: range 2-3 y)
1 Randomized trials Serious§ Not serious Not serious Very serious†† None
Lack of retention (follow-up: range 4-7 y)—not reported
— — — — — — —
Lack of retention (follow-up: range 7 y or more)—not reported
— — — — — — —
* Source: Pardi and colleagues.e18
† The percentages (30% and 70%) indicate the control group baseline risk (caries prevalence).
‡ Only 1 study reported this outcome. No subgroup analysis was conducted.
§ All risk of bias domains were classified as unclear.
¶ 95% confidence interval suggests a large benefit and a large harm (95% confidence interval, 89% reduction-82% increase). Only 9 events are
informing this outcome.
# The study was conducted in water-fluoridated communities.
** Dashes indicate data not available.
†† 95% confidence interval suggests a large benefit and a large harm (95% confidence interval, 48% reduction-166% increase). Only 27 events are
informing this outcome.
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eTABLE 5 (CONTINUED)
PATIENTS (N) EFFECT QUALITY IMPORTANCE
Resin-Modified
Glass Ionomer
Sealants
Polyacid-Modified
Resin Sealants†
Relative Odds Ratio
(95% Confidence
Interval)
Absolute (95% Confidence
Interval)
3/97 (3.1%) 6/89 (6.7%)# 0.44 (0.11-1.82) 37 fewer per 1,000 (49 more-60
fewer)
Very low Critical
30.0% 141 fewer per 1,000 (138 more-255
fewer)
70.0% 193 fewer per 1,000 (109 more-496
fewer)
— — — — —
— — — — —
15/97 (15.5%) 12/89 (13.5%) 1.17 (0.52-2.66) 19 more per 1,000 (60 fewer-158
more)
Very low Important
— — — — —
— — — — —
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eTABLE 6
Evidence profile: polyacid-modified resin sealants compared with resin-based
sealants in pit-and-fissure occlusal surfaces in children and adolescents.*
QUALITY ASSESSMENT
No. of Studies Study Design Risk of Bias Inconsistency Indirectness Imprecision Other Considerations
Caries incidence (follow-up: range 2-3 y)‡
2 Randomized trials Serious§ Not serious Not serious Very serious¶ None
Caries incidence (follow-up: range 4-7 y)—not reported
—** — — — — — —
Caries incidence (follow-up: range 7 y or more)—not reported
— — — — — — —
Lack of retention (follow-up: range 2-3 y)
2 Randomized trials Serious§ Serious†† Not serious Serious‡‡ None
Lack of retention (follow-up: range 4-7 y)—not reported
— — — — — — —
Lack of retention (follow-up: range 7 y or more)—not reported
— — — — — — —
* Sources: Gungor and colleaguese22 and Pardi and colleagues.e18
† The percentages (30% and 70%) indicate the control group baseline risk (caries prevalence).
‡ The studies only reported the outcome in patients who were caries-free. No subgroup analysis was conducted.
§ The 2 studies were classified as “unclear” risk of bias for the domain “allocation concealment.”
¶ 95% confidence interval suggests a large benefit and a large harm (95% confidence interval, 52% reduction-114% increase).
# 1 of 2 studies reported being conducted in water-fluoridated communities.
** Dashes indicate data not available.
†† Unexplained heterogeneity (P < .00001, I2 ¼ 97%).
‡‡ 95% confidence interval suggests a large benefit and a large harm (95% confidence interval, 88% reduction-521% increase).
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eTABLE 6 (CONTINUED)
PATIENTS (N) EFFECT QUALITY IMPORTANCE
Polyacid-Modified
Resin Sealants
Resin-Based
Sealants†
Relative Odds Ratio
(95% Confidence
Interval)
Absolute (95% Confidence
Interval)
16/159 (10.1%) 16/163 (9.8%)# 1.01 (0.48 to 2.14) 1 more per 1,000 (49 fewer-91
more)
Very low Critical
30.0% 2 more per 1,000 (129 fewer-178
more)
70.0% 2 more per 1,000 (133 more-172
fewer)
— — — — —
— — — — —
15/159 (9.4%) 15/163 (9.2%) 0.87 (0.12-6.21) 11 fewer per 1,000 (80 fewer-294
more)
Very low Important
— — — — —
— — — — —
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